Clinical Trials Search Results Display: Title Description with: Locations Eligibility Full Trial Description Custom ? Hide Search Criteria Show Search Criteria Drug: navitoclaxFind trials that include: Any drugs shown Results 1-4 of 4 for your search: Start Over Select All on Page Sort by: Phase of Trial Title Type of Trial Status of Trial Age Range Trial ID Show 10 25 50 100 200 Results per Page 1. Trametinib and Navitoclax in Treating Patients with Advanced or Metastatic Solid Tumors Status: ActivePhase: Phase II, Phase IType: Biomarker/Laboratory analysis, TreatmentAge: 18 and overTrial IDs: 9525, NCI-2014-00461, 13-505, NCT02079740 2. Dabrafenib, Trametinib, and Navitoclax in Treating Patients with BRAF Mutant Melanoma or Solid Tumors That Are Metastatic or Cannot Be Removed by Surgery Status: ActivePhase: Phase II, Phase IType: Biomarker/Laboratory analysis, TreatmentAge: 18 and overTrial IDs: 9466, NCI-2013-02103, 13-424, NCT01970956, NCT01989585 3. Navitoclax and Sorafenib Tosylate in Treating Patients with Relapsed or Refractory Solid Tumors Status: Temporarily closedPhase: Phase IType: Biomarker/Laboratory analysis, TreatmentAge: 18 and overTrial IDs: 9608, NCI-2014-01043, MC1315, NCT02143401 4. Osimertinib and Navitoclax in Treating Patients with EGFR-Positive Previously Treated Advanced or Metastatic Non-small Cell Lung Cancer Status: ActivePhase: Phase IType: Biomarker/Laboratory analysis, TreatmentAge: 18 and overTrial IDs: 9903, NCI-2015-01270, 16-714, NCT02520778 Select All on Page Start Over
